Pelthos Therapeutics (NYSEAM:PTHS) FY Conference December 04, 2025 09:30 AM ET Company ParticipantsScott Plesha - CEOModeratorWelcome to Day Three of the Piper Sandler Healthcare Conference. This is David Amsellem from the Piper Biopharma Research Team. We're delighted to kick off today with Pelthos Therapeutics and CEO Scott Plesha. Thanks, Scott, for joining us. I'm going to dive right in. You had some favorable news on Zelzuvmi this morning on the payer front, so kind of hot off the presses. Maybe just g ...